← Back to Search

E-Nose Breathprint Testing for Mesothelioma

N/A

Recruiting

Led By Gaetano Rocco, MD

Research Sponsored by Memorial Sloan Kettering Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Aged 30-85 years

No history of thoracic cancer or extrathoracic cancer potentially involving pleural metastases (i.e., breast, gastric, colon, or pancreas cancer)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 1 year

Awards & highlights

Study Summary

This trial tests a new tech (E-Nose) to see how people respond to standard treatment for mesothelioma. It will measure changes in E-Nose breathprints, imaging scans & biomarkers in blood.

Who is the study for?

This trial is for adults aged 30-85 who have recently been diagnosed with malignant pleural mesothelioma (MPM) and haven't had thoracic cancer or cancers like breast, gastric, colon, or pancreas that could spread to the chest. Participants must consent to all study procedures.Check my eligibility

What is being tested?

The study is testing E-Nose technology which analyzes breathprints to see how well patients respond to standard MPM treatments. It compares these breathprints over time with imaging scans and blood biomarkers related to MPM.See study design

What are the potential side effects?

Since this trial involves non-invasive E-Nose testing and research blood tests rather than drug interventions, side effects are minimal but may include discomfort from the breathing test or bruising from blood draws.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 30 and 85 years old.

Select...

I have never had cancer in my chest or cancer from the breast, stomach, colon, or pancreas that has spread to the lining of my lungs.

Select...

I have recently been diagnosed with mesothelioma.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change of MPMspecific VOCs

Trial Design

1Treatment groups

Experimental Treatment

Group I: E-Nose TechnologyExperimental Treatment2 Interventions

Patients will undergo E-Nose testing at baseline (before any treatment is administered) and at three points after treatment (1, 3, and 6 months). Patients will undergo E-Nose testing in a presurgical or interventional radiology suite.

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Memorial Sloan Kettering Cancer CenterLead Sponsor

1,936 Previous Clinical Trials

588,878 Total Patients Enrolled

19 Trials studying Mesothelioma

777 Patients Enrolled for Mesothelioma

UNIVERSITY CAMPUS BIO-MEDICO, ITALYUNKNOWN

Gaetano Rocco, MDPrincipal InvestigatorMemorial Sloan Kettering Cancer Center

2 Previous Clinical Trials

329 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this clinical trial include elderly participants?

"This medical research opportunity is seeking willing participants that are between 30 and 85 years old."

Answered by AI

Are there currently any openings to participate in this research trial?

"Confirmed, the trial is currently open for enrolment. This clinical study was posted on September 8th of 2023 and edited on the same date according to records available from clinicaltrials.gov"

Answered by AI

Who has been approved to participate in this experiment?

"This medical trial has a strict eligibility criterion: patients should be between 30 and 85 years old, with mesothelioma. A maximum of 20 participants will be accepted into the study."

Answered by AI

How extensive is the sample size for this clinical trial?

"Affirmative. Clinicaltrials.gov houses data indicating that this trial, initially posted on September 8th 2023, is still in the recruitment phase. The research team is looking to enrol a total of 20 patients at 7 separate locations."

Answered by AI

How many venues are hosting this investigation?

"This research project is being conducted at seven sites, among them the Memorial Sloan Kettering Monmouth (Consent Only) in Middletown and the Memorial Sloan Kettering Westchester (Consent Only) in Harrison. Additionally, four other medical centres are contributing to this trial's success."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Using E-Nose Technology to Measure Response to Treatment in People With Malignant Pleural Mesothelioma

2023. "Using E-Nose Technology to Measure Response to Treatment in People With Malignant Pleural Mesothelioma". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06037941.

All > Mesothelioma